Apotex Holdings Inc. completes sale of Accucaps Industries to Catalent Pharma Solutions
Overview
On February 16, 2017, Catalent Pharma Solutions Ltd. announced the completion of its purchase of all of the shares of Accucaps Industries Ltd. from Apotex Holdings Inc. for an undisclosed price.
Accucaps is a developer and manufacturer of over-the-counter pharmaceutical softgels and operates two state-of-the art softgel development, manufacturing and packaging facilities in Windsor and Strathroy, Ont. The acquisition complements and enhances Catalent’s global network of 11 softgel technology facilities.
Apotex Holdings Inc. was represented by Torkin Manes LLP, with a team led by Jeffrey Cohen and including Sammy Redlick and Adrian Myers.
To read the complete details in Lexpert Magazine, click here.
People
-
Jeff is the Managing Partner of Torkin Manes, with a practice primarily focused on multifaceted mergers, acquisitions and dispositions of businesses, as well as a wide variety of complex business transactions and financings.
View bio
-
Sammy has extensive experience in mergers and acquisitions, corporate finance, private equity and general corporate/commercial law matters across a range of industries. View bio
-
Adrian provides counsel to clients in a wide range of commercial and business law matters, including mergers and acquisitions, debt and equity financing, corporate reorganizations, commercial contracts, and corporate governance arrangements. View bio
